SynthesisOrphanet journal of rare diseases2024

A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases.

Shailja Vaghela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.